Incannex Healthcare Limited (#ASX: $IHL) has received positive results from pre-clinical animal study for the assessment of the key constituents of IHL-675A against sepsis associated acute respiratory distress syndrome. https://t.co/NqpHPZ9QFc. #CannabisMedicinal #stocks #Covid19 https://t.co/99zRQLyy2c